Edwards Lifesciences Corp.
(NYSE : EW)

( )
EW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. 0.39%163.700.7%$416.26m
MDTMedtronic Plc 0.62%121.030.6%$395.39m
ABTAbbott Laboratories 0.28%90.050.8%$367.24m
ISRGIntuitive Surgical, Inc. 0.27%601.652.4%$344.91m
TMOThermo Fisher Scientific, Inc. -0.53%337.381.0%$285.90m
BSXBoston Scientific Corp. -0.45%44.081.1%$285.86m
BDXBecton, Dickinson & Co. 0.16%277.531.1%$259.57m
SYKStryker Corp. 1.16%214.631.3%$251.80m
BAXBaxter International, Inc. 1.51%91.081.8%$219.83m
EWEdwards Lifesciences Corp. 1.40%241.971.2%$208.38m
ABMDABIOMED, Inc. 4.76%189.913.3%$205.28m
ALGNAlign Technology, Inc. -2.68%273.176.4%$186.15m
DXCMDexCom, Inc. 0.36%231.628.3%$166.19m
NVSTEnvista Holdings Corp. 1.50%32.510.0%$138.40m
IDXXIDEXX Laboratories, Inc. -0.34%284.843.7%$128.46m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..